Earnings History Data for Biocept, Inc. (BIOC) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Biocept, Inc.

Biocept, Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept, Inc. is headquartered in San Diego, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-11-2021	AH	4:05 PM ET (Nov 15)	BIOC	Biocept, Inc.	56.24	0.03	0.09	-0.43	Biocept EPS misses by $0.04, beats on revenue [11/15/2021 4:08 PM]	3.90	-0.09 (-2.26%)	3.85	-0.14 (-3.51%)	3.26 - 8.38	227,917	180,000	2,015
Biocept EPS misses by $0.04, beats on revenue [11/15/2021 4:08 PM] Biocept Reports Third Quarter 2021 Financial Results [Nov-15-21 04:05PM]
16-08-2021	AH	4:05 PM ET (Aug 16)	BIOC	Biocept, Inc.	55.89	-0.14	0.00	-0.50	Biocept EPS beats by $0.02, beats on revenue [8/16/2021 4:06 PM]	3.44	-0.35 (-9.23%)	3.45	-0.34 (-8.97%)	3.37 - 9.39	492,742	250,000	17,877
Biocept EPS beats by $0.02, beats on revenue [8/16/2021 4:06 PM] Biocept Reports Second Quarter 2021 Financial Results [Aug-16-21 04:05PM] Biocept Stock Drops Despite Clocking Q2 Sales Of $12M [Aug-17-21 11:22AM]
12-05-2021	AH	4:05 PM ET (May 12)	BIOC	Biocept, Inc.	59.91	0.19	0.00	-0.80	Biocept reports Q1 results [5/12/2021 4:12 PM]	4.28	-0.48 (-10.08%)	4.31	-0.45 (-9.45%)	3.46 - 13.00	319,755	210,000	58,932
Biocept reports Q1 results [5/12/2021 4:12 PM] Biocept shares fall ~13% despite swinging to Q1 profit and major revenue increase [5/13/2021 8:43 AM] Biocept, Inc. to Host Earnings Call [May-12-21 02:30PM] Biocept Reports First Quarter 2021 Financial Results [May-12-21 04:05PM]
29-03-2021	AH	4:05 PM ET (Mar 29)	BIOC	Biocept, Inc.	72.88	0.14	0.00	2.00	Biocept EPS beats by $0.41, beats on revenue [3/29/2021 4:09 PM]	5.28	0.13 (2.52%)	6.35	1.20 (23.30%)	2.54 - 13.00	3,727,254	500,000	946,961
Biocept EPS beats by $0.41, beats on revenue [3/29/2021 4:09 PM] Biocept surges as revenue and earnings beat consensus [3/29/2021 5:35 PM] Biocept, Inc. to Host Earnings Call [Mar-29-21 02:30PM] Biocept Reports 2020 Fourth Quarter and Full Year Financial Results [Mar-29-21 04:05PM] Biocept: Q4 Earnings Insights [Mar-29-21 04:32PM] The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings [Mar-30-21 08:06AM]
12-11-2020	AH	4:05 PM ET (Nov 12)	BIOC	Biocept, Inc.	6.17	-0.43	-0.48	-2.50	Biocept EPS beats by $0.04, beats on revenue [11/12/2020 4:08 PM]	4.78	-1.38 (-22.48%)	5.18	-0.98 (-15.91%)	2.11 - 13.00	2,049,901	611,180	91,912

12-08-2020	AH	4:05 PM ET (Aug 12)	BIOC	Biocept, Inc.	145.52	-0.50	-0.04	-0.38	Biocept EPS in-line, misses on revenue [8/12/2020 4:13 PM]	1.04	0.02 (1.96%)	1.15	0.13 (12.75%)	0.21 - 1.30	18,549,003	42,767,280	5,767,665